178 related articles for article (PubMed ID: 32034059)
1. Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets.
Bahmad HF; Poppiti RJ
J Clin Pathol; 2020 May; 73(5):243-249. PubMed ID: 32034059
[TBL] [Abstract][Full Text] [Related]
2. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Liu X; Ding C; Tan W; Zhang A
Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
5. BMI1 is a therapeutic target in recurrent medulloblastoma.
Bakhshinyan D; Venugopal C; Adile AA; Garg N; Manoranjan B; Hallett R; Wang X; Mahendram S; Vora P; Vijayakumar T; Subapanditha M; Singh M; Kameda-Smith MM; Qazi M; McFarlane N; Mann A; Ajani OA; Yarascavitch B; Ramaswamy V; Farooq H; Morrissy S; Cao L; Sydorenko N; Baiazitov R; Du W; Sheedy J; Weetall M; Moon YC; Lee CS; Kwiecien JM; Delaney KH; Doble B; Cho YJ; Mitra S; Kaplan D; Taylor MD; Davis TW; Singh SK
Oncogene; 2019 Mar; 38(10):1702-1716. PubMed ID: 30348991
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma stem cells.
Fan X; Eberhart CG
J Clin Oncol; 2008 Jun; 26(17):2821-7. PubMed ID: 18539960
[TBL] [Abstract][Full Text] [Related]
7. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.
Huang GH; Xu QF; Cui YH; Li N; Bian XW; Lv SQ
Cancer Sci; 2016 May; 107(5):583-9. PubMed ID: 27171351
[TBL] [Abstract][Full Text] [Related]
9. IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.
Folgiero V; Miele E; Carai A; Ferretti E; Alfano V; Po A; Bertaina V; Goffredo BM; Benedetti MC; Camassei FD; Cacchione A; Locatelli F; Mastronuzzi A
Oncotarget; 2016 Aug; 7(33):52900-52911. PubMed ID: 27174915
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
[TBL] [Abstract][Full Text] [Related]
11. Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma.
Eckerdt F; Bell JB; Beauchamp EM; Clymer J; Blyth GT; Kosciuczuk EM; Ma Q; Chen DZ; Horbinski C; Goldman S; Munshi HG; Hashizume R; Platanias LC
Mol Cancer Res; 2019 Jun; 17(6):1305-1315. PubMed ID: 30842251
[TBL] [Abstract][Full Text] [Related]
12. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
13. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
14. Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ; Bowers DC
CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
[TBL] [Abstract][Full Text] [Related]
15. The rationale for targeted therapies in medulloblastoma.
MacDonald TJ; Aguilera D; Castellino RC
Neuro Oncol; 2014 Jan; 16(1):9-20. PubMed ID: 24305711
[TBL] [Abstract][Full Text] [Related]
16. Detection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastoma.
Huang CJ; Lee CL; Liu CY; Huang SH; Hou JW; Chen YH; Chien CC; Ho CM; Lo WC; Hung KL
Int J Mol Med; 2017 May; 39(5):1195-1205. PubMed ID: 28339008
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells.
Frasson C; Rampazzo E; Accordi B; Beggio G; Pistollato F; Basso G; Persano L
Biomed Res Int; 2015; 2015():973912. PubMed ID: 26557719
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma stem cells: modeling tumor heterogeneity.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
[TBL] [Abstract][Full Text] [Related]
20. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]